Tatro Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$866K Sell
8,559
-176
-2% -$18.5K 0.65% 30
2021
Q4
$901K Buy
8,735
+683
+8% +$63.1K 0.65% 28
2021
Q3
$683K Buy
8,052
+165
+2% +$13.8K 0.53% 36
2021
Q2
$658K Buy
7,887
+781
+11% +$64K 0.45% 43
2021
Q1
$535K Buy
+7,106
New +$518K 0.41% 44

Other funds holding CVS

Tatro Capital's CVS Position: Q1 2022 in Review

Tatro Capital reduced its CVS Health (CVS) stake by 2% in Q1 2022, selling an estimated $18.5K and leaving 8,559 shares worth $866K. The position accounts for 0.65% of the portfolio, ranked #30.

Tatro Capital first reported a position in CVS in Q1 2021 and has held it in 5 quarters since. The position peaked at $901K in Q4 2021. 2,366 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • Tatro Capital held 8,559 shares of CVS Health worth $866K as of Q1 2022.
  • Tatro Capital sold 176 CVS Health shares in Q1 2022, an estimated $18.5K.
  • CVS Health made up 0.65% of Tatro Capital's portfolio in Q1 2022, its #30 holding.
  • Tatro Capital first reported a position in CVS Health in Q1 2021 and has held it in 5 quarters since.
  • Tatro Capital's CVS Health position peaked at $901K in Q4 2021.
  • 2,366 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on Tatro Capital's 13F filing for Q1 2022, filed 13 May 2022.